Skip to search formSkip to main contentSkip to account menu

iodoazomycin arabinoside

Known as: 1-(5-iodo-5-deoxy-beta-arabinofuranosyl)-2-nitroimidazole, IAZA 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
PVC based membranes of a double armed crown ether, N, N'-dibenzyl, 1,4,10,13-tetraoxa-7, 16-diaza cyclooctadecane (I) as… 
2003
2003
The present work describes the synthesis of the b-isomer of 1-a-D-(5-deoxy-5-iodoarabinofuranosyl)-2-nitroimidazole (IAZA… 
2001
2001
UNLABELLED 123I-Labeled iodoazomycin arabinoside (IAZA) is a marker of hypoxia in vivo. It has been used clinically to image… 
1999
1999
123I-labelled iodoazomycin arabinoside (123I-IAZA) is an experimental radiopharmaceutical that has been shown to have clinical… 
Highly Cited
1996
Highly Cited
1996
Tumour oxygenation status in individual patients may be assessed using the bioreduction and linkage of 2-nitroimidazole markers… 
1996
1996
Second-generation nuclear medicine markers of tumour hypoxia have been synthesised and screened for hypoxic marking activity in… 
Highly Cited
1991
Highly Cited
1991
1-(5-Iodo-5-deoxy-beta-D-arabinofuranosyl)-2-nitroimidazole (IAZA) has been synthesised and labeled with 125I. Radioiodinated…